According to Pharmala Biotech Holdings latest financial reports the cash on hand of MDMA is $143.26K, an decrease of -77.11% to 2022. At the end of 2022 company had $625.90K cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $143.26K | -77.11% |
2022 | $625.90K | -65.53% |
2021 | $1.82M | - |